Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?

WCG Van Staveren, DYW Solís, A Hebrant… - … et Biophysica Acta (BBA …, 2009 - Elsevier
Established human cancer cell lines are routinely used as experimental models for human
cancers. Their validity for such use is analyzed and discussed, with particular focus on …

Thyroid cancer cell lines: an overview

M Saiselet, S Floor, M Tarabichi, G Dom… - Frontiers in …, 2012 - frontiersin.org
Human thyroid cancer cell lines are the most used models for thyroid cancer studies. They
must be used with detailed knowledge of their characteristics. These in vitro cell lines …

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification

RE Schweppe, JP Klopper, C Korch… - The Journal of …, 2008 - academic.oup.com
Context: Cell lines derived from human cancers provide critical tools to study disease
mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell …

Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration

A Ferreira-da-Silva, C Valacca, E Rios, H Pópulo… - PloS one, 2015 - journals.plos.org
Oncocytic cell tumors are characterized by the accumulation of morphologically abnormal
mitochondria in their cells, suggesting a role for abnormal mitochondrial biogenesis in …

STAT3 negatively regulates thyroid tumorigenesis

JP Couto, L Daly, A Almeida, JA Knauf… - Proceedings of the …, 2012 - National Acad Sciences
Although tyrosine-phosphorylated or activated STAT3 (pY-STAT3) is a well-described
mediator of tumorigenesis, its role in thyroid cancer has not been investigated. We observed …

PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [89Zr]Zr-TR1402

GR Gimblet, HA Houson, J Whitt, P Reddy… - Molecular …, 2024 - ACS Publications
Thyroid cancer is the most common endocrine cancer, with differentiated thyroid cancers
(DTCs) accounting for 95% of diagnoses. While most DTC patients are diagnosed and …

CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer

H Li, X Zhou, G Wang, D Hua, S Li, T Xu… - The Journal of …, 2022 - academic.oup.com
Background Chimeric antigen receptor T cells (CAR-Ts) have demonstrated remarkable
efficacy in hematological cancers but have not yet translated in treating solid tumors. The …

Targeting the TSH receptor in thyroid cancer

CW Rowe, JW Paul, C Gedye… - Endocrine-Related …, 2017 - erc.bioscientifica.com
Recent advances in the arena of theranostics have necessitated a re-examining of
previously established fields. The existing paradigm of therapeutic thyroid-stimulating …

Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti‐invasive Activity in Preclinical Models of Human Thyroid Cancer

C Nucera, MA Nehs, SS Nagarkatti, PM Sadow… - The …, 2011 - academic.oup.com
Abstract Purpose. B‐RafV600E may play a role in the progression from papillary thyroid
cancer to anaplastic thyroid cancer (ATC). We tested the effects of a highly selective B …

TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis

L Wang, H Tan, Y Huang, M Guo… - Endocrine-related …, 2023 - erc.bioscientifica.com
TAGLN2, an actin-binding protein, functions as a binding protein to actin to facilitate the
formation of intracellular cytoskeleton structures. TAGLN2 overexpression in papillary …